{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:11:34Z","timestamp":1769551894736,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1038\/sj.bjc.6601379","type":"journal-article","created":{"date-parts":[[2003,11,11]],"date-time":"2003-11-11T18:44:36Z","timestamp":1068576276000},"page":"1876-1884","source":"Crossref","is-referenced-by-count":18,"title":["Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2"],"prefix":"10.1038","volume":"89","author":[{"given":"Y","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ohshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kawabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Hihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Toge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,11,11]]},"reference":[{"key":"BF6601379_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s002620050250","volume":"42","author":"S Bruno","year":"1996","unstructured":"Bruno S, Machi AM, Semino C, Meta M, Ponte M, Varaldo M, Curotto A, Ferlazzo G, Decensi A, Melioli G (1996) Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. Cancer Immunol Immunother 42: 47\u201354","journal-title":"Cancer Immunol Immunother"},{"key":"BF6601379_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000050630","volume":"22","author":"SA Bustin","year":"2001","unstructured":"Bustin SA, Li SR, Phillips S, Dorudi S (2001) Expression of HLA class II in colorectal cancer: evidence for enhanced immunogenicity of microsatellite-instability-positive tumors. Tumor Biol 22: 294\u2013298","journal-title":"Tumor Biol"},{"key":"BF6601379_CR3","first-page":"5320","volume":"57","author":"DJ Cole","year":"1997","unstructured":"Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI (1997) T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cancer Res 57: 5320\u20135327","journal-title":"Cancer Res"},{"key":"BF6601379_CR4","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.1073\/pnas.161260098","volume":"98","author":"PG Coulie","year":"2001","unstructured":"Coulie PG, Karanikas V, Colau D, Lurquin C, Landry C, Marchand M, Dorval T, Brichard V, Boon T (2001) A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci USA 98: 10290\u201310295","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6601379_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1183\/09031936.94.07101889","volume":"7","author":"P Driesen","year":"1994","unstructured":"Driesen P, Boutin C, Viallat JR, Astoul PH, Vialette JP, Pasquier J (1994) Implantable access system for prolonged intrapleural immunotherapy. Eur Respir J 7: 1889\u20131892","journal-title":"Eur Respir J"},{"key":"BF6601379_CR6","first-page":"2153","volume":"42","author":"C Ericsson","year":"2001","unstructured":"Ericsson C, Seregard S, Bartolazzi A, Levitskaya E, Ferrone S, Kiessling R, Larsson O (2001) Association of HLA class I and class II antigen expression and mortality in uveal melanoma. Invest Ophthalmol Vis Sci 42: 2153\u20132156","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6601379_CR7","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.4049\/jimmunol.158.12.5619","volume":"158","author":"T Fujimoto","year":"1997","unstructured":"Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O'Donnell MA (1997) Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol 158: 5619\u20135626","journal-title":"J Immunol"},{"key":"BF6601379_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1054\/bjoc.2000.1599","volume":"84","author":"A Gochi","year":"2001","unstructured":"Gochi A, Orita K, Fuchimoto S, Tanaka N, Ogawa N (2001) The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients. Br J Cancer 84: 443\u2013451","journal-title":"Br J Cancer"},{"key":"BF6601379_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-065X.1995.tb00684.x","volume":"146","author":"S Hahn","year":"1995","unstructured":"Hahn S, Gehri R, Erb P (1995) Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 146: 57\u201379","journal-title":"Immunol Rev"},{"key":"BF6601379_CR10","first-page":"1077","volume":"19","author":"J Hihara","year":"1999","unstructured":"Hihara J, Yamaguchi Y, Minami K, Noma K, Toge T (1999) Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion. Anticancer Res 19: 1077\u20131084","journal-title":"Anticancer Res"},{"key":"BF6601379_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/bbrc.1997.6459","volume":"233","author":"M Hsiao","year":"1997","unstructured":"Hsiao M, Tse V, Carmel J, Tsai Y, Felgner PL, Haa M, Silverberg GD (1997) Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival. Biochem Biophys Res Commun 233: 359\u2013364","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6601379_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/BF02221331","volume":"3","author":"M Katano","year":"1991","unstructured":"Katano M, Kubota E, Yamamoto H, Nakamura M, Matsuo T, Hisatsugu T, Katsuki T, Koga H, Ikezaki K, Tabuchi K (1991) A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy. Biotherapy 3: 373\u2013379","journal-title":"Biotherapy"},{"key":"BF6601379_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/1097-0142(19820701)50:1<62::AID-CNCR2820500113>3.0.CO;2-0","volume":"50","author":"M Katano","year":"1982","unstructured":"Katano M, Torisu M (1982) Neutrophil-mediated tumor cell destruction in cancer ascites. Cancer 50: 62\u201368","journal-title":"Cancer"},{"key":"BF6601379_CR14","first-page":"365","volume":"93","author":"M Katano","year":"1983","unstructured":"Katano M, Torisu M (1983) New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction. Surgery 93: 365\u2013373","journal-title":"Surgery"},{"key":"BF6601379_CR15","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1054\/bjoc.2001.2160","volume":"85","author":"LS Kierstead","year":"2001","unstructured":"Kierstead LS, Ranieri E, Olson W, Brusic V, Sidney J, Sette A, Kasamon YL, Slingluff Jr CL, Kirkwood JM, Storkus WJ (2001) gp100\/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+ T cells. Br J Cancer 85: 1738\u20131745","journal-title":"Br J Cancer"},{"key":"BF6601379_CR16","first-page":"2547","volume":"18","author":"M Kimura","year":"1998","unstructured":"Kimura M, Konno T, Miyamoto Y, Kojima Y, Maeda H (1998) Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses. Anticancer Res 18: 2547\u20132550","journal-title":"Anticancer Res"},{"key":"BF6601379_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0305-7372(93)90032-M","volume":"19","author":"DW Miles","year":"1993","unstructured":"Miles DW, Knight RK (1993) Diagnosis and management of malignant pleural effusion. Cancer Treat Rev 19: 151\u2013168","journal-title":"Cancer Treat Rev"},{"key":"BF6601379_CR18","first-page":"242","volume":"1","author":"E Miyahara","year":"1996","unstructured":"Miyahara E, Yamaguchi Y, Hihara J, Noma K, Toge T (1996) Profile of T-cell receptor V\u03b2 gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions. J Exp Ther Oncol 1: 242\u2013250","journal-title":"J Exp Ther Oncol"},{"key":"BF6601379_CR19","first-page":"2057","volume":"19","author":"E Miyahara","year":"1999","unstructured":"Miyahara E, Yamaguchi Y, Minami K, Hihara J, Noma K, Toge T, Takafuta T, Fujimura K (1999) T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients. Anticancer Res 19: 2057\u20132066","journal-title":"Anticancer Res"},{"key":"BF6601379_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/1097-0142(19920201)69:3<636::AID-CNCR2820690306>3.0.CO;2-W","volume":"69","author":"T Monden","year":"1992","unstructured":"Monden T, Morimoto H, Shimano T, Yagyu T, Murotani M, Nagaoka H, Kawasaki Y, Kobayashi T, Mori T (1992) Use of fibrinogen to enhance the antitumor effect of OK-432. A new approach to immunotherapy for colorectal carcinoma. Cancer 69: 636\u2013642","journal-title":"Cancer"},{"key":"BF6601379_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02179041","volume":"5","author":"H Nagaoka","year":"1992","unstructured":"Nagaoka H, Monden T, Sakita I, Katsumoto Y, Wakasugi T, Kawasaki Y, Tomita N, Takeda T, Yagyu T, Morimoto H (1992) Establishment of cytotoxic CD4+ T cell clones from cancer patients treated by local immunotherapy. Biotherapy 5: 241\u2013250","journal-title":"Biotherapy"},{"key":"BF6601379_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0192-0561(91)90100-L","volume":"13","author":"M Nanjo","year":"1991","unstructured":"Nanjo M, Moriya Y, Hashimoto S, Kataoka M, Saito M, Yoshida T, Ishida N (1991) Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines. Int J Immunopharmacol 13: 205\u2013215","journal-title":"Int J Immunopharmacol"},{"key":"BF6601379_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjc.6690421","volume":"80","author":"Y Nio","year":"1999","unstructured":"Nio Y, Nagami H, Tamura K, Tsubono M, Nio M, Sato M, Kawabata K, Hayashi H, Shiraishi T, Imai S, Tsuchitani T, Mizuta J, Nakagawa M, Fukumoto M (1999) Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion. Br J Cancer 80: 775\u2013785","journal-title":"Br J Cancer"},{"key":"BF6601379_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF01878152","volume":"7","author":"K Ogawa","year":"1993","unstructured":"Ogawa K, Katsube T, Hirai M, Yagawa H, Kajiwara T, Saito M, Hashimoto S, Yoshida T (1993) The presence of a common antigen between human gastric cancer cells and OK-432. Biotherapy 7: 39\u201345","journal-title":"Biotherapy"},{"key":"BF6601379_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/0888-7543(89)90129-8","volume":"5","author":"M Orita","year":"1989","unstructured":"Orita M, Suzuki Y, Sekiya TI, Hayashi K (1989) Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874\u2013879","journal-title":"Genomics"},{"key":"BF6601379_CR26","first-page":"4630","volume":"50","author":"S Ozaki","year":"1990","unstructured":"Ozaki S, Suginoshita T, Watanabe T, Obayashi H (1990) Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells. Cancer Res 50: 4630\u20134634","journal-title":"Cancer Res"},{"key":"BF6601379_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/cbr.1996.11.177","volume":"11","author":"MK Sgagias","year":"1996","unstructured":"Sgagias MK, Nieroda C, Yannelli JR, Cowan KH, Danforth Jr DN (1996) Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures. Cancer Biother Radiopharm 11: 177\u2013185","journal-title":"Cancer Biother Radiopharm"},{"key":"BF6601379_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00004836-200204000-00006","volume":"34","author":"M Shibata","year":"2002","unstructured":"Shibata M, Nezu T, Kanou H, Abe H, Takekawa M, Fukuzawa M (2002) Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer. J Clin Gastroenterol 34: 416\u2013420","journal-title":"J Clin Gastroenterol"},{"key":"BF6601379_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2%3C253::AID-IJC17%3E3.0.CO;2-U","volume":"85","author":"R Somasundaram","year":"2000","unstructured":"Somasundaram R, Robbins P, Moonka D, Loh E, Malincola F, Patel A, Guerry D, Herlyn D (2000) CD4(+), HLA class I-restricted, cytotoxic T-lymphocyte clone against primary malignant melanoma cells. Int J Cancer 85: 253\u2013259","journal-title":"Int J Cancer"},{"key":"BF6601379_CR30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.4049\/jimmunol.152.3.1127","volume":"152","author":"T Stalder","year":"1994","unstructured":"Stalder T, Hahn S, Erb P (1994) Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 152: 1127\u20131133","journal-title":"J Immunol"},{"key":"BF6601379_CR31","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.1073\/pnas.82.24.8624","volume":"82","author":"B Toyonaga","year":"1985","unstructured":"Toyonaga B, Yoshika Y, Vadasz V, Chin B, Mak T (1985) Organization and sequences of the diversity, joining, and constant region gene of the human T-cell receptor \u03b2 chain. Proc Natl Acad Sci USA 82: 8624\u20138628","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6601379_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-2478(85)90074-4","volume":"10","author":"A Uchida","year":"1985","unstructured":"Uchida A, Klein E (1985) Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors. Immunol Lett 10: 177\u2013181","journal-title":"Immunol Lett"},{"key":"BF6601379_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.2910310102","volume":"31","author":"A Uchida","year":"1983","unstructured":"Uchida A, Micksche M (1983) Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells. Int J Cancer 31: 1\u20135","journal-title":"Int J Cancer"},{"key":"BF6601379_CR34","first-page":"2201","volume":"15","author":"Y Yamaguchi","year":"1995","unstructured":"Yamaguchi Y, Satoh Y, Miyahara E, Noma K, Funakoshi M, Takashima I, Sawamura A, Toge T (1995) Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients. Anticancer Res 15: 2201\u20132206","journal-title":"Anticancer Res"},{"key":"BF6601379_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0169-5002(00)00136-7","volume":"30","author":"T Yano","year":"2000","unstructured":"Yano T, Sugio K, Yamazaki K, Kase S, Yamaguchi M, Ondo K, Sugimachi K (2000) Direct influence of interferon-gamma on proliferation and cell-surface antigen expression of non-small cell lung cancer cells. Lung Cancer 30: 169\u2013174","journal-title":"Lung Cancer"},{"key":"BF6601379_CR36","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.4049\/jimmunol.162.10.6100","volume":"162","author":"M Yasukawa","year":"1999","unstructured":"Yasukawa M, Ohminami H, Yakushijin Y, Arai J, Hasegawa A, Ishida Y, Fujita S (1999) Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells. J Immunol 162: 6100\u20136106","journal-title":"J Immunol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601379","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T10:13:03Z","timestamp":1704967983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601379"}},"subtitle":["Induction of autologous tumour-reactive CD4+ Th1 killer lymphocytes"],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["BF6601379"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601379","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}